Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2024) 102 108 | DOI: 10.1530/endoabs.102.108

EYES2024 ESE Young Endocrinologists and Scientists (EYES) 2024 Pituitary and Neuroendocrinology (7 abstracts)

Double trouble: adipsic diabetes insipidus and panhypopituitarism in isolated hypothalamo-pituitary langerhans cell histiocytosis

Charmi Gandhi 1 , Sarbesh Tiwari 2 , Mohit Agrawal 3 , Nandeesh BN 4 , Bharti Devnani 5 & Ravindra Shukla 1


1Department of Endocrinology, All India Institute of Medical Sciences, Jodhpur, India; 2Department of Diagnostic and Interventional Radiology, All India Institute of Medical Sciences, Jodhpur, India; 3Department of Neurosurgery, All India Institute of Medical Sciences, Jodhpur, India; 4Department of Neuropathology, National Institute of Mental Health and Neurosciences, Bengaluru, India; 5Department of Radiation Oncology, All India Institute of Medical Sciences, Jodhpur, India


Introduction: Langerhans cell histiocytosis (LCH) is a multi-organ disease characterized by clonal proliferation of immature dendritic cells. Isolated hypothalamo-pituitary (HP-LCH) involvement is rare and the coexistence of empty sella syndrome (ESS) is even rarer. We report a case of LCH with ESS and adipsia presenting as life-threatening hypernatremia.

Case presentation: A previously healthy 26-year-old woman presented with amenorrhea, headaches, somnolence, high-grade fever, altered behavior, cognitive decline and inability to recognize relatives. Her relatives noted her loss of thirst sensation. She was delirious and dehydrated with initial investigations revealing hypernatremia (Na-172 mEq/l) with Acute Kidney Injury (Urea-48 mg/dl, Creatinine-1.97 mg/dl), Serum Osmolality 387-mOsm/kg and Urine Osmolality-747 mOsm/kg. Fluid replacement uncovered the co-existing Arginine Vasopressin deficiency (AVP-D). MRI Brain showed T1/T2 iso-intense heterogeneously enhancing irregular suprasellar lesion (2.6 × 1.9 × 2 cm) with loss of interface with hypothalamus, basal ganglia and midbrain, partial empty sella and absent posterior pituitary bright spot. Anterior pituitary workup revealed 8 am cortisol-1.36 mg/dl, TSH-2.312 mIU/l, fT4-0.46 ng/dl, fT3-2.03 pg/ml, Prolactin-0.25 ng/ml, IGF-1-55.42 ng/ml, FSH-0.59 mIU/ml, LH-<0.01 mIU/l. Serum and CSF AFP and HCG were negative. Hormonal treatment was initiated. Whole-body PET-CT showed FDG-avid (SUVmax-25.56) well-defined suprasellar irregular soft tissue density, measuring 1.5 × 2 cm. Stereotactic diagnostic Brain Biopsy was performed. IHC was strongly positive for CD1a, compatible with LCH. 20Gy/10# Radiotherapy (RT) given using VMAT Technique. 6 weeks post RT, her cognition and thirst sensation has returned and 30% radiological improvement was noted.

Conclusion: LCH should be considered in cases of adipsia with AVP-D, even in the absence of other systemic features. Isolated HP-LCH can easily be misdiagnosed; therefore, a biopsy is necessary for an accurate diagnosis to initiate timely and targeted therapy. Adipsia with cognitive impairment led to life-threatening hypernatremia, posing significant management challenges that required ongoing caregiver counseling and support. This case highlights the essential role of a multidisciplinary approach in navigating the complexities of this disease.

Volume 102

ESE Young Endocrinologists and Scientists (EYES) 2024

European Society of Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches.